myelosuppressive therapy

myelosuppressive therapy

Oncology Any therapy intended to inhibit or frankly wipe out normal cell proliferation in the BM. Cf Myelosuppression.

Myelosuppressive therapy

Any form of treatment that is aimed at slowing down the rate of blood cell production.
Mentioned in: Polycythemia Vera
References in periodicals archive ?
Therefore, ESAs are not indicated for use in oncology patients with CKD who are receiving myelosuppressive therapy if the intent is to cure the patient.
A randomized, non-inferiority study of recombinant human G-CSF/human serum albumin fusion (CG-10639) and pegfilgrastim in breast cancer patients receiving myelosuppressive therapy.
Treatment strategies include using bland rinses for mild to moderate oral mucositis pain, topical anesthetics, and prophylactic antiviral and antifungal therapy in patients undergoing myelosuppressive therapy to prevent infections that can aggravate oral mucositis.
Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy. Leuk Lymphoma 2000;37: 189-95.
Patients administered mildly myelosuppressive therapy are at low risk.